Cetera Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-800
Closed -$728 4169
2025
Q1
$728 Hold
800
﹤0.01% 3971
2024
Q4
$4.24K Hold
800
﹤0.01% 3744
2024
Q3
$2.57K Buy
800
+100
+14% +$8.41K ﹤0.01% 3695
2024
Q2
$3.36K Sell
700
-100
-13% -$8.2K ﹤0.01% 3690
2024
Q1
$2.07K Buy
800
+400
+100% +$34.1K ﹤0.01% 3672
2023
Q4
$960 Hold
400
﹤0.01% 2223
2023
Q3
$2.74K Hold
400
﹤0.01% 2183
2023
Q2
$944 Sell
400
-100
-20% -$8.61K ﹤0.01% 2179
2023
Q1
$800 Sell
500
-100
-17% -$8.15K ﹤0.01% 2151
2022
Q4
$4.26K Buy
+600
New +$48.6K ﹤0.01% 2091

Other funds holding MDT

Cetera Investment Advisers's MDT Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Medtronic (MDT) stake by 11% in Q2 2026, selling an estimated $6.32M and leaving 618,387 shares worth $48.4M. The position accounts for 0.04% of the portfolio, ranked #420.

Cetera Investment Advisers first reported a position in MDT in Q3 2017 and has held it in 36 quarters since. The position peaked at $62.3M in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cetera Investment Advisers held 618,387 shares of Medtronic worth $48.4M as of Q2 2026.
  • Cetera Investment Advisers sold 78,380 Medtronic shares in Q2 2026, an estimated $6.32M.
  • Medtronic made up 0.04% of Cetera Investment Advisers's portfolio in Q2 2026, its #420 holding.
  • Cetera Investment Advisers first reported a position in Medtronic in Q3 2017 and has held it in 36 quarters since.
  • Cetera Investment Advisers's Medtronic position peaked at $62.3M in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.